OptiNose Stock (NASDAQ: OPTN) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 697.000 / 1.079M |
Day Range | - - - |
52 Wk Range | 0.800 - 2.100 |
Market Cap | $98.897M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | 3.19% |
Days to Cover | 2.63 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of OptiNose (NASDAQ: OPTN) through any online brokerage.
Other companies in OptiNose’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), Jaguar Health (NASDAQ:JAGX), Rani Therapeutics Hldgs (NASDAQ:RANI), Marinus Pharma (NASDAQ:MRNS) and Alimera Sciences (NASDAQ:ALIM).
The latest price target for OptiNose (NASDAQ: OPTN) was reported by HC Wainwright & Co. on Monday, April 29, 2024. The analyst firm set a price target for 5.00 expecting OPTN to rise to within 12 months (a possible 469.54% upside). 6 analyst firms have reported ratings in the last year.
The stock price for OptiNose (NASDAQ: OPTN) is $0.8779 last updated Today at May 3, 2024 at 5:50 AM EDT.
There are no upcoming dividends for OptiNose.
OptiNose’s Q1 earnings are confirmed for Friday, May 17, 2024.
There is no upcoming split for OptiNose.
OptiNose is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.